Gene: TMEM150A
Official Full Name: transmembrane protein 150Aprovided by HGNC
Gene Summary: Involved in phosphatidylinositol phosphate biosynthetic process and protein localization to plasma membrane. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26684 | TMEM150A Knockout cell line (HeLa) | Human | TMEM150A | 1:3~1:6 | Negative | Online Inquiry |
KO26685 | TMEM150A Knockout cell line (HCT 116) | Human | TMEM150A | 1:2~1:4 | Negative | Online Inquiry |
KO26686 | TMEM150A Knockout cell line (HEK293) | Human | TMEM150A | 1:3~1:6 | Negative | Online Inquiry |
KO26687 | TMEM150A Knockout cell line (A549) | Human | TMEM150A | 1:3~1:4 | Negative | Online Inquiry |
TMEM150A Gene Knockout Cell Lines represent a cutting-edge tool for researchers aiming to elucidate the functional roles of the TMEM150A gene within various biological contexts. These cell lines are engineered using CRISPR-Cas9 technology to achieve a precise knockout of the TMEM150A gene, enabling researchers to investigate the gene's involvement in cellular processes such as ion transport, signaling pathways, and cellular stress responses. By eliminating the expression of this gene, scientists can gain critical insights into its function and the physiological implications of its loss.
The unique mechanism by which the TMEM150A knockout is achieved ensures specificity and efficiency, allowing for the study of gene function in a controlled manner. When paired with assays measuring cell proliferation, migration, and apoptosis, these cell lines provide an invaluable model to study diseases linked to dysfunctional TMEM150A expression, including certain types of cancer and neurodegenerative disorders.
In research and clinical settings, the availability of these knockout lines is paramount, as they facilitate the investigation of the TMEM150A gene's role in pathophysiological conditions, contributing to the understanding of potential therapeutic targets. Compared to traditional knockdown mechanisms, such as RNA interference, gene knockout offers a more permanent alteration, enabling a thorough analysis of gene function without the transient effects associated with other methods.
Investing in TMEM150A Gene Knockout Cell Lines will empower researchers and clinicians to enhance their studies by providing an advanced model that bridges fundamental research with clinical application. The comprehensive data gathered from these experiments can significantly influence the development of novel treatment strategies.
With extensive experience in the development of genetically modified cell lines, our company is dedicated to providing high-quality biological research tools that accelerate scientific discovery. Our commitment to innovation and excellence ensures you have access to the best resources for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.